Clinical Trials Directory

If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test

We are doing this study to learn more about how right hemisphere brain damage (RHD) from a stroke can affect people's ability to communicate. We want to improve treatments to help stroke survivors regain their ability to communicate.

We are doing this study to find out if an investigational drug, CTX-471, is safe and effective against your cancer.

We are doing this study to compare the study drug, lutetium-177 edotreotide, to existing standard-of-care therapies.

We want to find out if a study drug called larotrectinib is an effective treatment for brain tumors in children and young adults. We want to learn how well it works to shrink brain tumors when used alone or when given with standard chemotherapy or after radiation therapy.

We are doing this study to see whether programs are helpful for couples where one partner has cancer.

We are doing this study to learn about the social, ethical, and behavioral outcomes of COVID-19 prevention practices in schools, and to find out whether these practices have any differential impact toward students of color. We want to learn from the perspectives of Black and Latino/a/x students and caregivers of Black and Latino/a/x students in Durham County Public and Charter Schools.

Estamos realizando este estudio para aprender sobre los resultados sociales, éticos y de comportamiento de las prácticas de prevención de COVID-19 en las escuelas, y para averiguar si es que estas prácticas tienen cualquier impacto diferencial hacia los estudiantes de color. Queremos aprender a través de las perspectivas de los estudiantes Afro-descendientes y Latinos y de padres/guardianes de estudiantes Afro-descendientes y Latinos de las escuelas públicas y chárter en el condado de Durham.

We are doing this study to learn more about the immune response patients with X-linked Agammaglobulinemia (XLA) have to COVID-19 vaccination. We will compare their immune responses to those of healthy people who have normal immune systems. Better understanding of cellular responses to COVID-19 vaccines by XLA patients is important since XLA patients cannot make antibodies to vaccines.

If you are interested, please contact the study team at XLACOVIDvax@duke.edu.